Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brad Spellberg

Showing results (171-180 of 267) with videos related to

Pageof 27
Sort By:
Antimicrobial Agents and Chemotherapy|May 13, 2009
Safety and outcomes of open-label deferasirox iron chelation therapy for mucormycosisBrad Spellberg, David Andes, Mario Perez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 4, 2008
The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of AmericaBrad Spellberg, Robert Guidos, David Gilbert, et al.
The American Journal of Medicine|October 29, 2021
Oral Is the New IV. Challenging Decades of Blood and Bone Infection Dogma: A Systematic ReviewNoah Wald-Dickler, Paul D Holtom, Matthew C Phillips, et al.
Jac-Antimicrobial Resistance|January 12, 2023
Fidaxomicin to prevent recurrent <i>Clostridioides difficile</i>: what will it cost in the USA and Canada?Devangi Patel, Julien Senecal, Brad Spellberg, et al.
Ophthalmology|August 6, 2025
Outpatient Oral Doxycycline Versus Intravenous Penicillin for Syphilitic UveitisYicheng K Bao, Jodi Hwang, Christopher Long, et al.
The Journal of Infectious Diseases|April 19, 2008
Antibody titer threshold predicts anti-candidal vaccine efficacy even though the mechanism of protection is induction of cell-mediated immunityBrad Spellberg, Ashraf S Ibrahim, Lin Lin, et al.
Msphere|May 13, 2017
Selectable Markers for Use in Genetic Manipulation of Extensively Drug-Resistant (XDR) <i>Acinetobacter baumannii</i> HUMC1Brian M Luna, Amber Ulhaq, Jun Yan, et al.
JAMA Network Open|December 6, 2024
Outpatient Oral Doxycycline Therapy for Ocular SyphilisYicheng K Bao, Jodi Hwang, Christopher Long, et al.
Msphere|May 29, 2020
Horizontal Gene Transfer of Antibiotic Resistance from Acinetobacter baylyi to Escherichia coli on Lettuce and Subsequent Antibiotic Resistance Transmission to the Gut MicrobiomeMarlène Maeusli, Bosul Lee, Sarah Miller, et al.
Antimicrobial Agents and Chemotherapy|January 14, 2009
Voriconazole use for endemic fungal infectionsAlison Freifeld, Laurie Proia, David Andes, et al.
Pageof 27

Showing results (171-180 of 267) with videos related to

Sort By:
Pageof 27
Antimicrobial Agents and Chemotherapy|May 13, 2009
Safety and outcomes of open-label deferasirox iron chelation therapy for mucormycosisBrad Spellberg, David Andes, Mario Perez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 4, 2008
The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of AmericaBrad Spellberg, Robert Guidos, David Gilbert, et al.
The American Journal of Medicine|October 29, 2021
Oral Is the New IV. Challenging Decades of Blood and Bone Infection Dogma: A Systematic ReviewNoah Wald-Dickler, Paul D Holtom, Matthew C Phillips, et al.
Jac-Antimicrobial Resistance|January 12, 2023
Fidaxomicin to prevent recurrent <i>Clostridioides difficile</i>: what will it cost in the USA and Canada?Devangi Patel, Julien Senecal, Brad Spellberg, et al.
Ophthalmology|August 6, 2025
Outpatient Oral Doxycycline Versus Intravenous Penicillin for Syphilitic UveitisYicheng K Bao, Jodi Hwang, Christopher Long, et al.
The Journal of Infectious Diseases|April 19, 2008
Antibody titer threshold predicts anti-candidal vaccine efficacy even though the mechanism of protection is induction of cell-mediated immunityBrad Spellberg, Ashraf S Ibrahim, Lin Lin, et al.
Msphere|May 13, 2017
Selectable Markers for Use in Genetic Manipulation of Extensively Drug-Resistant (XDR) <i>Acinetobacter baumannii</i> HUMC1Brian M Luna, Amber Ulhaq, Jun Yan, et al.
JAMA Network Open|December 6, 2024
Outpatient Oral Doxycycline Therapy for Ocular SyphilisYicheng K Bao, Jodi Hwang, Christopher Long, et al.
Msphere|May 29, 2020
Horizontal Gene Transfer of Antibiotic Resistance from Acinetobacter baylyi to Escherichia coli on Lettuce and Subsequent Antibiotic Resistance Transmission to the Gut MicrobiomeMarlène Maeusli, Bosul Lee, Sarah Miller, et al.
Antimicrobial Agents and Chemotherapy|January 14, 2009
Voriconazole use for endemic fungal infectionsAlison Freifeld, Laurie Proia, David Andes, et al.
Pageof 27